SCHEMBL8874598

SCHEMBL8874598

Cc1cc(CC(C)O)c(C)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.43
▸ ELANE P08246 2/20 0.41
▸ CYP1A1 P04798 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HBB P68871 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ AURKA O14965 1/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ MAPT P10636 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2397940 0.83 TTR (0.46) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL8876073 0.81 TTR (0.41) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL7160042 0.77 NPSR1 (0.51) TTRMEN1KMT2ANSD2
SCHEMBL6905929 0.75 ELANE (0.52) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL15848431 0.74 ALDH1A1 (0.46) ELANEALDH1A1CYP3A4L3MBTL1MAPK1
SCHEMBL8874594 0.74 TTR (0.44) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL8876477 0.73 TTR (0.43) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL8876069 0.72 TTR (0.40) TTRELANEALDH1A1SMN1; SMN2AURKB
SCHEMBL2256190 0.70 ADORA2A (0.53) TTRELANECYP1A1CYP1A2ALDH1A1
SCHEMBL21451669 0.70 TTR (0.46) TTRELANECYP1A1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5650399-A CONJUGATED WITH TARGET SPECIFIC OLIGONUCLEOTIDE, ACTIVATED BY LIGHT OR CHEMICAL/ENZYMATIC REDUCTION, ALKYLATION AND CROSSLINKING OF BIOLOGICAL MOLECULES SUCH DNA, ANTITUMOR THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1997-07-22 — — US disclosed
Send feedback